Mark Neumann Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Neumann.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Neumann. Mark Neumann is EVP, Chief Commercial Officer in Intra-Cellular Therapies, Inc. ($ITCI).
Latest Insider Trading Transactions of Mark Neumann
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 11,139 | 0 | 22,278 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 38.90 | 600 | 23,340 | 45,339 | 45.9 K to 45.3 K (-1.31 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 39.26 | 4,584 | 179,968 | 45,939 | 50.5 K to 45.9 K (-9.07 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 11,139 | 0 | 50,523 | 39.4 K to 50.5 K (+28.28 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 20,948 | 0 | 20,948 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 32.02 | 9,684 | 310,082 | 39,384 | 49.1 K to 39.4 K (-19.74 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 20,948 | 0 | 49,068 | 28.1 K to 49.1 K (+74.50 %) |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 13,448 | |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 26.80 | 6,792 | 182,026 | 28,120 | 34.9 K to 28.1 K (-19.45 %) |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 34,912 | 21.5 K to 34.9 K (+62.65 %) |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 33,417 | 0 | 33,417 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 23.94 | 26,754 | 640,491 | 26,754 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 20,947 | 0 | 41,896 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | J | 26.34 | 6,157 | 162,175 | 21,464 | 27.6 K to 21.5 K (-22.29 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 20,947 | 0 | 27,621 | 6.7 K to 27.6 K (+313.86 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 26,896 | |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 26,896 | |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 8.25 | 6,774 | 55,886 | 6,674 | 13.4 K to 6.7 K (-50.37 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 8.25 | 6,774 | 55,886 | 6,674 | 13.4 K to 6.7 K (-50.37 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 13,448 | 0 to 13.4 K |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 13,448 | 0 to 13.4 K |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 62,843 | 0 | 62,843 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 12.73 | 86,348 | 1,099,210 | 86,348 | |
| Oct 17 2018 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 40,344 | 0 | 40,344 | |
| Oct 17 2018 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 18.59 | 55,300 | 1,028,027 | 55,300 |
Page: 1